MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1)

References

• Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer. 2009;115(7):1531–1543.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.
   PubMed Web of Science ®Google Scholar
• Smrke A, Anderson PM, Gulia A, et al. Future directions in the treatment of osteosarcoma. Cells. 2021;10(1):172. DOI:10.3390/cells10010172.
   PubMed Web of Science ®Google Scholar
• Ruiz FJ, Sundaresan A, Zhang J, et al. Genomic characterization and therapeutic targeting of HPV undetected cervical carcinomas. Cancers (Basel). 2021;13(18):4551. DOI:10.3390/cancers13184551.
   PubMed Web of Science ®Google Scholar
• Hussen BM, Hidayat HJ, Salihi A, et al. MicroRNA: a signature for cancer progression. Biomed Pharmacother. 2021;138:111528.
   PubMed Web of Science ®Google Scholar
• Ali Syeda Z, Langden SSS, Munkhzul C, et al. Regulatory mechanism of microRNA expression in cancer. Int J Mol Sci. 2020;21(5):1723. DOI:10.3390/ijms21051723.
   PubMed Web of Science ®Google Scholar
• Tao X, Cheng J, Wang X. Effect of miRNA-200a on radiosensitivity of osteosarcoma cells by targeting bone morphogenetic protein receptor 2. Bioengineered. 2021;12(2):12625–12635.
   PubMed Web of Science ®Google Scholar
• Kim EH, Kim JY, Kim MS, et al. Molecular mechanisms underlying the enhancement of carbon ion beam radiosensitivity of osteosarcoma cells by miR-29b. Am J Cancer Res. 2020;10(12):4357–4371.
   PubMed Web of Science ®Google Scholar
• Yang Z, Wa QD, Lu C, et al. MiR‑328‑3p enhances the radiosensitivity of osteosarcoma and regulates apoptosis and cell viability via H2AX. Oncol Rep. 2018;39(2):545–553.
   PubMed Web of Science ®Google Scholar
• Xu Z, Chen L, Wang C, et al. MicroRNA-1287-5p promotes ferroptosis of osteosarcoma cells through inhibiting GPX4. Free Radic Res. 2021;55(11–12):1119–1129.
   PubMed Web of Science ®Google Scholar
• Chen Y, Huang T, Yang X, et al. MicroRNA-106a regulates the proliferation and invasion of human osteosarcoma cells by targeting VNN2. Oncol Rep. 2018;40(4):2251–2259.
   PubMed Web of Science ®Google Scholar
• Chen X, Luo H, Li X, et al. miR-331-3p functions as an oncogene by targeting ST7L in pancreatic cancer. Carcinogenesis. 2018;39(8):1006–1015.
   PubMed Web of Science ®Google Scholar
• Zhan T, Chen X, Tian X, et al. MiR-331-3p links to drug resistance of pancreatic cancer cells by activating WNT/β-Catenin signal via ST7L. Technol Cancer Res Treat. 2020;19:1533033820945801.
   Web of Science ®Google Scholar
• Buranjiang G, Kuerban R, Abuduwanke A, et al. MicroRNA-331-3p inhibits proliferation and metastasis of ovarian cancer by targeting RCC2. Arch Med Sci. 2019;15(6):1520–1529.
   PubMed Web of Science ®Google Scholar
• Tian QQ, Xia J, Zhang X, et al. miR-331-3p inhibits tumor cell proliferation, metastasis, invasion by targeting MLLT10 in non-small cell lung cancer. Cancer Manag Res. 2020;12:5749–5758.
   PubMed Web of Science ®Google Scholar
• Xuefang Z, Ruinian Z, Liji J, et al. miR-331-3p inhibits proliferation and promotes apoptosis of nasopharyngeal carcinoma cells by targeting elf4B-PI3K-AKT pathway. Technol Cancer Res Treat. 2020;19:1533033819892251.
   Web of Science ®Google Scholar
• Taniguchi N, Kizuka Y. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. Adv Cancer Res. 2015;126:11–51.
   PubMed Web of Science ®Google Scholar
• Boscher C, Dennis JW, Nabi IR. Glycosylation, galectins and cellular signaling. Curr Opin Cell Biol. 2011;23(4):383–392.
   PubMed Web of Science ®Google Scholar
• Beheshti Zavareh R, Sukhai MA, Hurren R, et al. Suppression of cancer progression by MGAT1 shRNA knockdown. PLoS One. 2012;7(9):e43721.
   PubMed Web of Science ®Google Scholar
• Akiva I, Birgul Iyison N. MGAT1 is a novel transcriptional target of Wnt/beta-catenin signaling pathway. BMC Cancer. 2018;18(1):60.
   PubMedGoogle Scholar
• Li Y, Liu Y, Zhu H, et al. N-acetylglucosaminyltransferase I promotes glioma cell proliferation and migration through increasing the stability of the glucose transporter GLUT1. FEBS Lett. 2020;594(2):358–366.
   PubMed Web of Science ®Google Scholar
• Liu G, Mao H, Liu Y, et al. miR-148b-3p, as a tumor suppressor, targets son of sevenless homolog 1 to regulate the malignant progression in human osteosarcoma. Bioengineered. 2022;13(2):4271–4284.
   PubMed Web of Science ®Google Scholar
• Dai W, Liu H. MicroRNA-886 suppresses osteosarcoma cell proliferation and its maturation is suppressed by long non-coding RNA OXCT1-AS1. Bioengineered. 2022;13(3):5769–5778.
   PubMed Web of Science ®Google Scholar
• Liu WG, Zhuo L, Lu Y, et al. Guo Q. miR-874-3p inhibits cell migration through targeting RGS4 in osteosarcoma. J Gene Med. 2020;22(9):e3213.
   PubMed Web of Science ®Google Scholar
• Young L, Sung J, Stacey G, et al. Detection of mycoplasma in cell cultures. Nat Protoc. 2010;5(5):929–934.
   PubMed Web of Science ®Google Scholar
• Zhao R, Song J, Jin Y, et al. Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating ErbB signaling pathway. J Mol Histol. 2021;52(5):991–1006.
   PubMed Web of Science ®Google Scholar
• Guo L, Fu J, Sun S, et al. MicroRNA-143-3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3. Cancer Sci. 2019;110(2):805–816.
   PubMed Web of Science ®Google Scholar
• Justus CR, Leffler N, Ruiz-Echevarria M, et al. In vitro cell migration and invasion assays. J vis exp. 2014;(88). DOI:10.3791/51046.
   PubMed Web of Science ®Google Scholar
• Wessel D, Flügge UI. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem. 1984;138(1):141–143.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Jiménez-Díaz MB, Mulet T, Gómez V, et al. Quantitative measurement of Plasmodium-infected erythrocytes in murine models of malaria by flow cytometry using bidimensional assessment of SYTO-16 fluorescence. Cytom Part A :j Int Soc Anal Cytol. 2009;75(3):225–235.
   PubMedGoogle Scholar
• Darzynkiewicz Z, Juan G, Bedner E. Determining cell cycle stages by flow cytometry. Curr Protoc Cell Biol. 2001;Chapter 8. Unit 8.4. DOI: 10.1002/0471143030.cb0804s01.
   PubMedGoogle Scholar
• Liu H, Song M, Sun X, et al. T-box transcription factor TBX1, targeted by microRNA-6727-5p, inhibits cell growth and enhances cisplatin chemosensitivity of cervical cancer cells through AKT and MAPK pathways. Bioengineered. 2021;12(1):565–577.
   PubMed Web of Science ®Google Scholar
• Fuchs B, Pritchard DJ. Etiology of osteosarcoma. Clin Orthop Relat Res. 2002;397:40–52.
   PubMed Web of Science ®Google Scholar
• Gibbs CP Jr., Weber K, Scarborough MT. Malignant bone tumors. Instr Course Lect. 2002;51:413–428.
   PubMedGoogle Scholar
• Rupaimoole R, Calin GA, Lopez-Berestein G, et al. miRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov. 2016;6(3):235–246.
   PubMed Web of Science ®Google Scholar
• Ram Kumar RM, Boro A, Fuchs B. Involvement and clinical aspects of microRNA in osteosarcoma. Int J Mol Sci. 2016;17(6):877 doi:10.3390/ijms17060877.
   PubMed Web of Science ®Google Scholar
• Ji Q, Xu X, Song Q, et al. miR-223-3p inhibits human osteosarcoma metastasis and progression by directly targeting CDH6. Mol ther. 2018;26(5):1299–1312.
   PubMed Web of Science ®Google Scholar
• Chen R, Ning Y, Zeng G, et al. The miR-193a-5p/NCX2/AKT axis promotes invasion and metastasis of osteosarcoma. J Cancer. 2021;12(19):5903–5913.
   PubMed Web of Science ®Google Scholar
• Liu W, Li X, Tan X, et al. MicroRNA-204-3p inhibits metastasis of pancreatic cancer via downregulating MGAT1. J B.U.ON: off J Balkan Union Oncol. 2021;26(5):2149–2156.
   PubMedGoogle Scholar
• Zhang Y, Wang X. Targeting the Wnt/beta-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13(1):165.
   PubMed Web of Science ®Google Scholar
• Xue Y, Guo Y, Liu N, et al. MicroRNA-22-3p targeted regulating transcription factor 7-like 2 (TCF7L2) constrains the Wnt/β-catenin pathway and malignant behavior in osteosarcoma. Bioengineered. 2021. DOI:10.1080/21655979.2021.2003942.
   Web of Science ®Google Scholar
• Zhang H, Liu S, Tang L, et al. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9). Bioengineered. 2021;12(1):162–171.
   PubMed Web of Science ®Google Scholar
• Liang K, Liao L, Liu Q, et al. microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/β-catenin signaling pathway. Clin Transl Oncol. 2021;23(11):2350–2357.
   PubMed Web of Science ®Google Scholar
• Mitschke J, Burk UC, Reinheckel T. The role of proteases in epithelial-to-mesenchymal cell transitions in cancer. Cancer Metastasis Rev. 2019;38(3):431–444.
   PubMed Web of Science ®Google Scholar
• Bakir B, Chiarella AM, Pitarresi JR, et al. EMT, MET, plasticity, and tumor metastasis. Trends Cell Biol. 2020;30(10):764–776.
   PubMed Web of Science ®Google Scholar
• Delbridge AR, Grabow S, Strasser A, et al. Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer. 2016;16(2):99–109.
   PubMed Web of Science ®Google Scholar
• Maes ME, Schlamp CL, Nickells RW. BAX to basics: how the BCL2 gene family controls the death of retinal ganglion cells. Prog Retin Eye Res. 2017;57:1–25.
   PubMed Web of Science ®Google Scholar
• Li XF, Zhao GQ, Li LY. Ginsenoside impedes proliferation and induces apoptosis of human osteosarcoma cells by down-regulating β-catenin. Cancer Biomark. 2019;24(4):395–404.
   PubMed Web of Science ®Google Scholar
• Hu W, Xiao Z. Formononetin induces apoptosis of human osteosarcoma cell line U2OS by regulating the expression of Bcl-2, Bax and MiR-375 in vitro and in vivo. Cell Physiol Biochem. 2015;37(3):933–939.
   PubMedGoogle Scholar